View in EDS

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.

Saved in:
Bibliographic Details
Title: UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
Authors: Liu S; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA., Chai T; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA., Garcia-Marques F; Department of Radiology, Stanford University, Palo Alto, CA, USA., Yin Q; Department of Radiology, Stanford University, Palo Alto, CA, USA., Hsu EC; Department of Radiology, Stanford University, Palo Alto, CA, USA., Shen M; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA., Shaw Toland AM; Department of Pathology, Stanford University, Stanford, CA, USA., Bermudez A; Department of Radiology, Stanford University, Palo Alto, CA, USA., Hartono AB; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA., Massey CF; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA., Lee CS; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA., Zheng L; Department of Radiology, Stanford University, Palo Alto, CA, USA., Baron M; Department of Pediatrics, Stanford University, Stanford, CA, USA; Department of Genetics, Stanford University, Stanford, CA, USA., Denning CJ; Department of Radiology, Stanford University, Palo Alto, CA, USA., Aslan M; Department of Radiology, Stanford University, Palo Alto, CA, USA., Nguyen HM; Department of Urology, University of Washington, Seattle, WA, USA., Nolley R; Department of Urology, Stanford University, Stanford, CA, USA., Zoubeidi A; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada., Das M; Department of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA; Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA., Kunder CA; Department of Pathology, Stanford University, Stanford, CA, USA., Howitt BE; Department of Pathology, Stanford University, Stanford, CA, USA., Soh HT; Department of Radiology, Stanford University, Palo Alto, CA, USA; Department of Electrical Engineering, Stanford University, Stanford, CA, USA., Weissman IL; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Department of Pathology, Stanford University, Stanford, CA, USA; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University, Stanford, CA, USA., Liss MA; Department of Urology, UT Health San Antonio, San Antonio, TX, USA., Chin AI; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA., Brooks JD; Department of Urology, Stanford University, Stanford, CA, USA., Corey E; Department of Urology, University of Washington, Seattle, WA, USA., Pitteri SJ; Department of Radiology, Stanford University, Palo Alto, CA, USA., Huang J; Department of Pathology, Duke University, Durham, NC, USA., Stoyanova T; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: tstoyanova@mednet.ucla.edu.
Source: Cell reports. Medicine [Cell Rep Med] 2024 Feb 20; Vol. 5 (2), pp. 101381. Date of Electronic Publication: 2024 Jan 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38244540
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liu+S%22">Liu S</searchLink>; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chai+T%22">Chai T</searchLink>; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Garcia-Marques+F%22">Garcia-Marques F</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yin+Q%22">Yin Q</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+EC%22">Hsu EC</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shen+M%22">Shen M</searchLink>; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shaw+Toland+AM%22">Shaw Toland AM</searchLink>; Department of Pathology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bermudez+A%22">Bermudez A</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hartono+AB%22">Hartono AB</searchLink>; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Massey+CF%22">Massey CF</searchLink>; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+CS%22">Lee CS</searchLink>; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+L%22">Zheng L</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Baron+M%22">Baron M</searchLink>; Department of Pediatrics, Stanford University, Stanford, CA, USA; Department of Genetics, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Denning+CJ%22">Denning CJ</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Aslan+M%22">Aslan M</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+HM%22">Nguyen HM</searchLink>; Department of Urology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Nolley+R%22">Nolley R</searchLink>; Department of Urology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zoubeidi+A%22">Zoubeidi A</searchLink>; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.<br /><searchLink fieldCode="AU" term="%22Das+M%22">Das M</searchLink>; Department of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA; Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kunder+CA%22">Kunder CA</searchLink>; Department of Pathology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Howitt+BE%22">Howitt BE</searchLink>; Department of Pathology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Soh+HT%22">Soh HT</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA; Department of Electrical Engineering, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Weissman+IL%22">Weissman IL</searchLink>; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Department of Pathology, Stanford University, Stanford, CA, USA; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liss+MA%22">Liss MA</searchLink>; Department of Urology, UT Health San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chin+AI%22">Chin AI</searchLink>; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Brooks+JD%22">Brooks JD</searchLink>; Department of Urology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Corey+E%22">Corey E</searchLink>; Department of Urology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Pitteri+SJ%22">Pitteri SJ</searchLink>; Department of Radiology, Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Huang+J%22">Huang J</searchLink>; Department of Pathology, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Stoyanova+T%22">Stoyanova T</searchLink>; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiology, Stanford University, Palo Alto, CA, USA; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: tstoyanova@mednet.ucla.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101766894%22">Cell reports. Medicine</searchLink> [Cell Rep Med] 2024 Feb 20; Vol. 5 (2), pp. 101381. <i>Date of Electronic Publication: </i>2024 Jan 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101766894 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3791 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663791%22">26663791 </searchLink><i>NLM ISO Abbreviation: </i>Cell Rep Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38244540
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.xcrm.2023.101381
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101381
    Titles:
      – TitleFull: UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu S
      – PersonEntity:
          Name:
            NameFull: Chai T
      – PersonEntity:
          Name:
            NameFull: Garcia-Marques F
      – PersonEntity:
          Name:
            NameFull: Yin Q
      – PersonEntity:
          Name:
            NameFull: Hsu EC
      – PersonEntity:
          Name:
            NameFull: Shen M
      – PersonEntity:
          Name:
            NameFull: Shaw Toland AM
      – PersonEntity:
          Name:
            NameFull: Bermudez A
      – PersonEntity:
          Name:
            NameFull: Hartono AB
      – PersonEntity:
          Name:
            NameFull: Massey CF
      – PersonEntity:
          Name:
            NameFull: Lee CS
      – PersonEntity:
          Name:
            NameFull: Zheng L
      – PersonEntity:
          Name:
            NameFull: Baron M
      – PersonEntity:
          Name:
            NameFull: Denning CJ
      – PersonEntity:
          Name:
            NameFull: Aslan M
      – PersonEntity:
          Name:
            NameFull: Nguyen HM
      – PersonEntity:
          Name:
            NameFull: Nolley R
      – PersonEntity:
          Name:
            NameFull: Zoubeidi A
      – PersonEntity:
          Name:
            NameFull: Das M
      – PersonEntity:
          Name:
            NameFull: Kunder CA
      – PersonEntity:
          Name:
            NameFull: Howitt BE
      – PersonEntity:
          Name:
            NameFull: Soh HT
      – PersonEntity:
          Name:
            NameFull: Weissman IL
      – PersonEntity:
          Name:
            NameFull: Liss MA
      – PersonEntity:
          Name:
            NameFull: Chin AI
      – PersonEntity:
          Name:
            NameFull: Brooks JD
      – PersonEntity:
          Name:
            NameFull: Corey E
      – PersonEntity:
          Name:
            NameFull: Pitteri SJ
      – PersonEntity:
          Name:
            NameFull: Huang J
      – PersonEntity:
          Name:
            NameFull: Stoyanova T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2024 Feb 20
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2666-3791
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cell reports. Medicine
              Type: main
ResultId 1